Antiplatelet and anticoagulation therapy for acute coronary syndromes. Review uri icon

Overview

abstract

  • The past 2 decades have witnessed the introduction and demise of several different antithrombotic medications for acute coronary syndromes. Part of the assessment of these compounds has been their effect on thrombotic events relative to the degree of increase in bleeding events. This review will outline the data supporting various antiplatelet and anticoagulant therapies and their combinations in patients with acute coronary syndromes and related disorders in both the acute and chronic phases of therapy.

publication date

  • June 6, 2014

Research

keywords

  • Acute Coronary Syndrome
  • Anticoagulants
  • Myocardial Infarction
  • Platelet Aggregation Inhibitors

Identity

Scopus Document Identifier

  • 84902188174

Digital Object Identifier (DOI)

  • 10.1161/CIRCRESAHA.114.302737

PubMed ID

  • 24902976

Additional Document Info

volume

  • 114

issue

  • 12